Modelling in tumour biology part 1: Modelling concepts and structures

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 87-94

  Rew, D A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CLINICAL RESEARCH; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TUMOR MODEL;

EID: 0033957112     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0747     Document Type: Review

References (43)

1. Watson JD, Crick FHC. Molecular structure of nucleic acids. Nature. 171:1953;737.
2. Howard A, Pelc SR. Nuclear incorporation of P-32 as demonstrated by autoradiographs. Exp Cell Res. 2:1951;178-187.
3. Gibbs JB, Oliff A. Pharmaceutical research in molecular oncology. Cell. 79:1994;193-198.
4. Rew DA. Tumour biology, chaos and non-linear dynamics. Eur J Surg Oncol. 25:1999;86-89.
5. Bernstein PL. Against the Gods. The remarkable story of risk. New York: John Wiley and Sons Inc. 1998.
6. Vogelstein B, Fearon ER, Hamilton SR. Genetic alterations during colorectal tumour development. New Eng J Med. 319:1988;525-532.
7. Weinberg R. A molecular basis of cancer. Sci Am. 249:1983;102-116.
8. Minden MD, Pawson AJ. Oncogenes. In: Tannock I, Hill RP (eds). The basic science of oncology, 2nd Edn. New York: McGraw Hill. 1992;61-87.
9. Hunter A. Oncoprotein networks. Cell. 88:1997;333-346.
10. Rew DA. Heterogeneity, biodiversity and bioperversity in human solid tumours. Eur J Surg Oncol. 22:1996;469-473.
11. Rew DA. Significance of aneuploidy. Br J Surg. 81:1994;1416-1422.
12. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 262:1993;1980-1981.
13. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
14. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montessano R, Harris C. Somatic point mutations in the p53 gene of human tumours and cell lines: updated compilation. Nucl Acid Res. 24:1996;141.
15. Alberts B. The cell as a collection of protein machines. Cell. 92:1998;291-294.
16. Welsh MJ, Robertson AD, Ostedgaard LS. The ABC of a versatile engine. Nature. 396:1998;623-624.
17. Rennie J. Immortal's enzyme. Sci Am. 271:1994;8-9.
18. Peters G. Cell cycle: stifled by inhibitions. Nature. 371:1994;204-205.
19. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science. 266:1994;1821-1828.
20. Rotenberg M (Ed.). Biomathematics and cell kinetics. New York: Elsevier Biomedical Press. 1981.
21. Lipkin M. Cell cycle and cancer. New York: Decker. 1971;1-26.
22. Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 6:1985;620-626.
23. Riccardi A, Danova M, Wilson GD, Ucci G, Dormer P, Mazzini G, Brugnatelli S, Girino M, McNally N, Ascari E. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res. 48:1988;6238-6245.
24. Kerr JFR, Wyllie AH, Currie AH. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br J Cancer. 26:1972;239-245.
25. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
26. Wyllie AH. Apoptosis. Br J Cancer. 67:1993;205-208.
27. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
28. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
29. Folkman J. Angiogenesis in cancer, vascular and rheumatoid disease. Nature Med. 1:1995;27-31.
30. Chaplain M, Anderson ARA. Mathematical modelling, simulation and prediction of tumour induced angiogenesis. Invasion Metastasis. 16:1996;222-234.
31. Garrod DR. Cell to cell and cell to matrix adhesion. Br Med J. 306:1993;703-705.
32. Menger MD, Vollmar B. Review: adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg. 83:1996;588-601.
33. Nicolson G. Cancer metastasis. Sci Am. 240:1979;50-60.
34. Jiang WG, Puntis MCA, Hallett MB. Molecular and cellular basis for cancer invasion and metastasis. Br J Surg. 81:1994;1576-1580.
35. Moeckel G, Keil M, Spiegelhalder B, Brickmann J. Local molecular properties of the p53 tumour suppressor protein-DNA interface. J Mol Model. www.dkfz-heidelberg.de/tox/welc_3d.htm (7.12.97). 2:1996;370-372.
36. Anon. Neural networks. ftp://ftp.sas.com/pub/neural/FAQ.html. (7.12.97).
37. Anon. Protein modelling. www.kal-el.ugr.es/k2d/spectra.html. (7.12.97).
38. Diahi JG, Frouge C, Giron A, Fertil B. Artificial neural networks for the detection of breast cancer in mammography. www.radonc.uchicago.edu/IWDM/IWDMa50.html. (7.12.97).
39. Niederberger C, Pursell SE, Golden RM. A neural network to predict lifespan and new metastases in patients with renal cell cancer. www.oup-usa.org/acadref/ncg5_4.html. (7.12.97.
40. Narayanswany R, Siewert S. Training neural networks to recognise cerival cancer cells. www-sgc.colorado.edu/people/siewerts/neural.html. (7.12.97).
41. Lee H-C. Thesis, University of Missouri-Rolla: skin cancer diagnosis using hierarchical neural networks and fuzzy logic. www.cs.umr.edu/hlee/thesis/thesis.html. (7.12.97).
42. Sherratt J. Report on mathematical modelling of cancer invasion and metastasis workshop, Univ. Warwick 1996. wwww.maths.wa.ac.uk/cancer_meeting.html. (7.12.97).
43. Anon. Fractal modelling of mammograms and segmentation of microcalcifications. http://dspserv.eng.umd.edu/project/Medical_Image.html. (7.12.97).